|
Uranium (insoluble compounds, as U) | CAS 7440-61-1 (metal) | ||
U (metal) | RTECS YR3490000 (metal) | ||
Synonyms & Trade Names Uranium metal: Uranium I Synonyms of other insoluble uranium compounds vary depending upon the specific compound. |
DOT ID & Guide 2979 162 (metal, pyrophoric) |
Exposure Limits |
NIOSH REL: Ca TWA 0.2 mg/m3 ST 0.6 mg/m3 See Appendix A | ||
OSHA PEL�: TWA 0.25 mg/m3 | |||
IDLH Ca [10 mg/m3 (as U)] | Conversion |
Physical Description Metal: Silver-white, malleable, ductile, lustrous solid. [Note: Weakly radioactive.] |
|||
MW: 238.0 |
BP: 6895°F |
MLT: 2097°F |
Sol: Insoluble |
VP: 0 mmHg (approx) |
IP: NA |
|
Sp.Gr: 19.05 (metal) |
Fl.P: NA |
UEL: NA |
LEL: NA |
MEC: 60 g/m3 |
Metal: Combustible Solid, especially turnings and powder. | |||
Incompatibilities & Reactivities Carbon dioxide, carbon tetrachloride, nitric acid, fluorine [Note: Complete coverage of uranium metal scrap with oil is essential for prevention of fire.] |
Measurement Methods None available |
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator with a high-efficiency particulate filter/Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, ingestion, skin and/or eye contact | |
Symptoms Dermatitis; kidney damage; blood changes; [potential occupational carcinogen]; in animals: lung, lymph node damage [Potential for cancer is a result of alpha-emitting properties & radioactive decay products (e.g., radon).] | |
Target Organs
Skin, kidneys, bone marrow, lymphatic system Cancer Site [lung cancer] |
See also: INTRODUCTION |